Heart and Lung Function Monitoring System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02168049|
Recruitment Status : Unknown
Verified June 2018 by Kimberly Howard-quijano, University of California, Los Angeles.
Recruitment status was: Recruiting
First Posted : June 20, 2014
Last Update Posted : June 12, 2018
|Condition or disease||Intervention/treatment||Phase|
|Heart Diseases Lung Diseases||Device: Integrated CardioRespiratory System Device: Transthoracic Echocardiography (TTE) Device: Electrocardiography||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Heart and Lung Function Monitoring System Evaluation|
|Study Start Date :||November 2014|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
|Experimental: Heart and Lung Function Monitioring||
Device: Integrated CardioRespiratory System
Participants will be asked to wear a non-invasive band on their upper abdomen while laying down. This band includes acoustic sensors. A remote monitoring device will continuously monitor and record heart rate and lung volumes and function.
Device: Transthoracic Echocardiography (TTE)
Participants will undergo a TTE examination. During the TTE, a technician obtains views of the heart by moving a small instrument called a transducer to different locations on the chest or abdominal wall.
Participants will also have ECG monitoring as part of the TTE exam, which records the electrical activity of the heart using electrodes placed on the body.
Other Name: ECG
- Acoustic heart sound electronic data [ Time Frame: 60 minutes during system trial ]Heart and lung function monitoring
- Standard echocardiography parameters [ Time Frame: 60 minutes during examination simultaneous with system trial ]Transthoracic Echocardiography (TTE)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02168049
|Contact: Jennifer Scovotti, M.A.||email@example.com|
|United States, California|
|Ronald Reagan UCLA Medical Center||Recruiting|
|Los Angeles, California, United States, 90095|
|Sub-Investigator: Aman Mahajan, M.D., Ph.D.|
|Sub-Investigator: William Kaiser, Ph.D.|
|Principal Investigator: Kimberly Howard-Quijano, M.D.|
|Principal Investigator:||Kimberly Howard-Quijano, M.D., M.S.||University of California, Los Angeles|